114
Participants
Start Date
March 31, 2018
Primary Completion Date
February 29, 2020
Study Completion Date
October 31, 2020
Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells
Cryopreserved Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells will be administered intravenously.
Placebo
Placebo, with excipients, will be administered intravenously.
Lead Sponsor
Canadian Institutes of Health Research (CIHR)
OTHER_GOV
Ontario Institute for Regenerative Medicine (OIRM)
UNKNOWN
Stem Cell Network
OTHER
Ottawa Hospital Research Institute
OTHER